ATROCAP study.

Methods	Atorvastatin and Thrombogenicity of the Carotid Atherosclerotic Plaque (ATROCAP) study. Six–centre randomized controlled trial.
Participants	59 participants undergoing bilateral CEA. Italy. Statin naive.
Interventions	Intervention group (N = 29) received 20 mg atorvastatin/day from day after 1st CEA  to after 2nd CEA. Intervention group (N = 30) received placebo. Mean duration, 133 (SD 63) days. Not clear when treatment was stopped.
Outcomes	No clinical outcomes reported. Endarterectomy specimens analysed for tissue factor and tissue factor pathway inhibitor antigens.
Notes	Unable to contact authors; emailed 20/8/12 and 27/9/12.